|
Age groups
| | | | | |
|
<40 years
|
2,264
|
(12.4)
|
2,545
|
(13.1)
| |
|
40-49 years
|
4,455
|
(24.3)
|
5,130
|
(26.5)
| |
|
50-59 years
|
4,358
|
(23.8)
|
4,567
|
(23.6)
| |
|
60-69 years
|
3,807
|
(20.8)
|
3,569
|
(18.4)
| |
|
70+ years
|
3,446
|
(18.8)
|
3,554
|
(18.4)
|
p < 0.01
|
|
Stage at diagnosis
| | | | | |
|
Local
|
9,884
|
(53.9)
|
9,306
|
(48.1)
| |
|
Regional
|
6,335
|
(34.6)
|
7,229
|
(37.3)
| |
|
Distant
|
815
|
(4.5)
|
851
|
(4.4)
| |
|
Missing
|
1,296
|
(7.1)
|
1,979
|
(10.2)
|
p < 0.01
|
|
Histology
| | | | | |
|
Ductal
|
12,906
|
(70.4)
|
13,333
|
(68.9)
| |
|
Lobular
|
1,166
|
(6.4)
|
1,051
|
(5.4)
| |
|
Mixed/Other
|
4,258
|
(23.2)
|
4,981
|
(25.7)
|
p < 0.01
|
|
Estrogen receptor (ER) status
| | | | | |
|
Positive
|
8,972
|
(49.0)
|
8,649
|
(44.7)
| |
|
Negative
|
3,551
|
(19.4)
|
3,822
|
(19.7)
| |
|
Other
|
5,807
|
(31.7)
|
6,894
|
(35.6)
|
p < 0.01
|
|
Grade
| | | | | |
|
Grade I
|
2,313
|
(12.6)
|
1,996
|
(10.3)
| |
|
Grade II
|
5,737
|
(31.3)
|
5,795
|
(29.9)
| |
|
Grade III
|
6,273
|
(34.2)
|
7,237
|
(37.4)
| |
|
Grade IV
|
473
|
(2.6)
|
536
|
(2.8)
| |
|
Unknown
|
3,534
|
(19.3)
|
3,801
|
(19.6)
|
p < 0.01
|
|
Chemotherapy treatment
| | | | | |
|
Yes
|
8,093
|
(44.2)
|
8,862
|
(45.8)
| |
|
No
|
9,821
|
(53.6)
|
9,845
|
(50.8)
| |
|
Missing
|
416
|
(2.3)
|
658
|
(3.4)
|
p < 0.01
|
|
Radiation treatment
| | | | | |
|
Yes
|
7,686
|
(41.9)
|
7,323
|
(37.8)
| |
|
No
|
10,643
|
(58.1)
|
12,042
|
(62.2)
| |
|
Missing
|
1
|
(<0.1)
|
0
|
(0)
|
p < 0.01
|
|
Surgery
| | | | | |
|
Yes
|
17,421
|
(95.0)
|
18,079
|
(93.4)
| |
|
No
|
891
|
(4.9)
|
1,268
|
(6.6)
| |
|
Missing
|
18
|
(0.1)
|
18
|
(0.1)
|
p < 0.01
|
|
Hormone therapy treatment
| | | | | |
|
Yes
|
5,461
|
(29.8)
|
5,116
|
(26.4)
| |
|
No
|
12,368
|
(67.5)
|
13,609
|
(70.3)
| |
|
Missing
|
501
|
(2.7)
|
640
|
(3.3)
|
p < 0.01
|
|
Number of lymph nodes
| | | | | |
|
0
|
9,514
|
(51.9)
|
8,800
|
(45.4)
| |
|
1-3
|
3,754
|
(20.5)
|
3,910
|
(20.2)
| |
|
≥4
|
2,592
|
(14.1)
|
3,261
|
(16.8)
| |
|
Missing
|
2,470
|
(13.5)
|
3,394
|
(17.5)
|
p < 0.01
|
|
Tumor size (mm)
| | | | | |
|
≤20 mm
|
1,601
|
(8.7)
|
1,814
|
(9.4)
| |
|
>20 mm
|
16,727
|
(91.3)
|
17,544
|
(90.6)
| |
|
Missing
|
2
|
(<0.1)
|
7
|
(<0.1)
|
p = 0.03
|
|
Neighborhood SES* (quintiles)
| | | | | |
|
1 (lowest)
|
4,030
|
(22.0)
|
6,971
|
(36.0)
| |
|
2
|
4,266
|
(23.3)
|
4,727
|
(24.4)
| |
|
3
|
4,092
|
(22.3)
|
3,389
|
(17.5)
| |
|
4
|
3,429
|
(18.7)
|
2,465
|
(12.7)
| |
|
5 (highest)
|
2,513
|
(13.7)
|
1,813
|
(9.4)
|
p < 0.01
|
|
Hispanic enclave (quintiles)
| | | | | |
|
1 (lowest)
|
2,080
|
(11.4)
|
859
|
(4.4)
| |
|
2
|
3,035
|
(16.6)
|
1,796
|
(9.3)
| |
|
3
|
3,786
|
(20.7)
|
2,722
|
(14.1)
| |
|
4
|
4,668
|
(25.5)
|
4,732
|
(24.4)
| |
|
5 (highest)
|
4,761
|
(26.0)
|
9,256
|
(47.8)
|
p < 0.01
|
|
Combined neighborhood SES* and Hispanic enclave**
| | | | | |
|
High SES, low enclave
|
7,255
|
(39.6)
|
4,525
|
(23.4)
| |
|
High SES, high enclave
|
2,779
|
(15.2)
|
3,142
|
(16.2)
| |
|
Low SES, low enclave
|
1,646
|
(9.0)
|
852
|
(4.4)
| |
|
Low SES, high enclave
|
6,650
|
(36.3)
|
10,846
|
(56.0)
|
p < 0.01
|
|
Vital Status
| | | | | |
|
Dead
|
5,976
|
(32.6)
|
6,018
|
(31.1)
| |
|
Alive
|
12,345
|
(67.4)
|
13,356
|
(68.9)
|
p < 0.01
|
|
Cause of death (N = 11,994)
| | | | | |
|
Breast cancer
|
3,464
|
(58.0)
|
3,654
|
(60.7)
| |
|
Other cancer
|
528
|
(8.8)
|
419
|
(7.0)
| |
|
Circulatory disease
|
938
|
(15.7)
|
782
|
(13.0)
| |
|
Other causes
|
882
|
(14.8)
|
638
|
(10.6)
| |
|
Unknown cause
|
164
|
(2.7)
|
525
|
(8.7)
|
p < 0.01
|
